Connect with us

Technology

4DMedical Receives TGA Approval for CT:VQ™, Bringing Non-Contrast Ventilation-Perfusion Imaging to Australia

Published

on

Non-contrast, ventilation-perfusion imaging—from routine chest CT scans

MELBOURNE, Australia, June 29, 2026 /PRNewswire/ — 4DMedical Limited (ASX: 4DX), the global leader in advanced respiratory imaging, today announced that CT:VQ™ technology has Therapeutic Goods Administration (TGA) approval and is included on the Australian Register of Therapeutic Goods (ARTG)—enabling commercial deployment across Australia.

CT:VQ™ gives physicians access to ventilation and perfusion imaging and data derived directly from routine, non-contrast, chest CT scans. CT:VQ™ delivers regional functional lung information without the use of injected contrast agents, radiotracers, or dedicated nuclear medicine infrastructure.

“TGA approval marks an important milestone for respiratory diagnostics in our home market,” said Andreas Fouras, Founder, Managing Director and CEO of 4DMedical.

“As the first and only, non-contrast, CT-based ventilation-perfusion imaging solution, CT:VQ™ gives healthcare providers detailed, functional lung information using infrastructure already available throughout the healthcare system. Plus, Australia’s high CT scanner density makes an attractive market for broad implementation.”

Ventilation-perfusion imaging typically requires dedicated nuclear medicine equipment, radiotracers, and specialized operational workflows. But CT:VQ™ provides a software-based alternative that integrates off scans performed from existing CT imaging infrastructure—potentially expanding access to functional lung assessment across a broader range of healthcare settings.

CT:VQ™ approval comes as healthcare systems increasingly seek scalable and affordable technologies that expand diagnostic capabilities by leveraging existing imaging resources. Using standard CT infrastructure already available across Australia, CT:VQ™ can broaden access to functional lung imaging in metropolitan, regional, and rural settings. CT:VQ™ can be particularly valuable for both facilities that lack onsite nuclear medicine services, and for hospitals and imaging centres that do, by helping preserve nuclear medicine capacity for their other diagnostic and therapeutic services.

Since receiving FDA clearance in 2025, CT:VQ™ has been deployed at leading U.S. institutions including Stanford, Cleveland Clinic, UC San Diego Health, University of Chicago Medicine, University of Miami, and SimonMed, one of the largest private outpatient radiology networks in the United States.

About 4DMedical

4DMedical Limited (ASX:4DX) is a global medical technology company revolutionising respiratory care with advanced imaging and artificial intelligence. Its patented XV Technology® transforms standard scans into rich, functional insights that allow physicians to detect, diagnose, and monitor lung disease earlier and with greater precision.

4DMedical’s expanding software portfolio includes the FDA-cleared XV Lung Ventilation Analysis Software (XV LVAS®), CT LVAS™, and the ground-breaking CT:VQ™ solution designed to set new benchmarks in cardiothoracic imaging by combining ventilation and perfusion analysis.

Delivered seamlessly through a Software-as-a-Service (SaaS) model, 4DMedical’s solutions integrate into existing hospital infrastructure, enhancing physician productivity and enabling more personalised patient care. With the addition of advanced AI capabilities from its 2023 acquisition of Imbio and 2026 acquisition of contextflow, 4DMedical continues to push the boundaries of medical imaging to redefine how respiratory disease is understood and treated worldwide.

Frequently Asked Questions

What is CT:VQ™?

CT:VQ™ is a non-contrast ventilation-perfusion imaging solution that derives regional lung function information from routine chest CT scans.

How does CT:VQ™ differ from a traditional V/Q scan?

Unlike conventional nuclear medicine ventilation-perfusion imaging, CT:VQ™ does not require radiotracers, injected contrast agents, specialized cameras, or dedicated nuclear medicine infrastructure. It uses scans produced from existing CT imaging resources to generate functional lung information.

Does CT:VQ™ require contrast agents or radioactive materials?

No. CT:VQ™ is a non-contrast imaging solution that does not require injected contrast agents, inhaled radiotracers, or radioactive isotopes.

Why is TGA approval important?

TGA approval allows CT:VQ™ to be commercially deployed across Australia and supports wider access to functional lung imaging using existing CT infrastructure already available in healthcare facilities nationwide.

Where is CT:VQ™ approved and in use?

CT:VQ™ holds regulatory clearance in Australia, the United States, European Union, United Kingdom, Canada, and New Zealand. It has been deployed at leading U.S. health systems including Stanford, Cleveland Clinic, UC San Diego Health, University of Chicago Medicine, University of Miami, and SimonMed, one of the largest private outpatient radiology networks in the United States.

Photo – https://mma.prnewswire.com/media/3001426/CTVQ_Web_Banner_Image_1920x1080_3_BW_Color.jpg
Logo – https://mma.prnewswire.com/media/2730645/4DMedical_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/4dmedical-receives-tga-approval-for-ctvq-bringing-non-contrast-ventilation-perfusion-imaging-to-australia-302812825.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Sungrow PowerKeeper Unlocks Greater Solar Value for Australian Medical Wholesaler

Published

on

By

SYDNEY, June 30, 2026 /PRNewswire/ — Sungrow, the globally leading PV inverter and energy storage system provider, has partnered with Smart Commercial Energy to deploy its PowerKeeper commercial energy storage solution for Team Medical Supplies, one of Australia’s largest medical wholesalers.

The project enables Team Medical Supplies to reduce electricity costs, increase solar self-consumption and strengthen energy resilience for temperature-sensitive medical products. With heavy reliance on cold rooms, freezers and air-conditioning to maintain critical storage conditions, the business sought a solution that could maximise the value of its existing solar investment while reducing exposure to rising energy costs.

PowerKeeper Unlocks Greater Value from Existing Solar Infrastructure

At the heart of the installation is Sungrow’s SH110CX commercial hybrid inverter paired with two 50 kWh PowerKeeper battery stacks (ST100CF), seamlessly integrated with the site’s existing 200 kW solar system.

The project presented a significant challenge from the start, in that the site’s existing switchboard constraints limited conventional battery integration options. Sungrow’s hybrid inverter SH110CX and PowerKeeper battery can be easily integrated with the site’s existing solar infrastructure, helping minimise installation complexity, reduce disruption and preserve the value of the customer’s previous solar investment.

“From an engineer’s perspective, there was this gap in the commercial market where we didn’t have any dedicated commercial hybrid inverters and battery systems. The PowerKeeper series serves as a perfect, elegant solution to commercial use cases where there is a single 110-kilowatt hybrid inverter that can take up to 250 kilowatt hours of battery, as well as 150kW of solar,” Liam Emmett, Project Engineer of Smart Commercial Energy.

“PowerKeeper is a game changer for commercial energy storage,” said Young Zhao, Service Manager of Sungrow Australia. “Its flexible design helps businesses overcome common site constraints while supporting multiple operating modes, including on-grid, off-grid and microgrid applications. This gives customers greater control over their energy usage while maximising the value of their solar investment.”

The solution also enables excess solar energy generated during the day to be stored and discharged when energy demand and electricity prices are higher, maximising self-consumption and improving overall energy efficiency.

“By storing excess solar energy generated during the day and using it when our cooling systems are running into the evening, we’ve reduced our reliance on the grid while improving the sustainability of our largest facility. The installation was straightforward, with no disruption to our operations, and the projected payback made it a compelling investment for the business,” said Tom Vriens, Co-CEO of Team Medical Supplies.

Today, the battery system supplies approximately 18% of the site’s post-solar energy consumption, reduces annual carbon emissions by an estimated 19 tonnes, and delivers a strong return on investment.

Delivering Long-Term Value Through Partnership

The collaboration between Sungrow and Smart Commercial Energy – Australia’s leading commercial battery installer in 2025 reflects a shared commitment to delivering practical, future-ready energy solutions. Through a staged approach, beginning with two stages of rooftop solar, followed by the hybrid inverter and battery, Smart Commercial Energy ensured Team Medical Supplies could adopt new technology at the right time and with strong commercial viability.

Building a Scalable Energy Future

With the system already delivering strong results, Team Medical Supplies is well positioned to expand its energy storage capacity as future needs evolve. Sungrow will continue working with partners across Australia to help businesses maximise the value of solar and storage through flexible, scalable energy solutions.

Contact:
Wang Luly
luly.wang@sungrow-hq.com 
+86 15618330862

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/sungrow-powerkeeper-unlocks-greater-solar-value-for-australian-medical-wholesaler-302814099.html

SOURCE Sungrow Power Supply Co., Ltd.

Continue Reading

Technology

Orqa and Remote Robotic Systems Launch $150M Partnership to Build Canadian Sovereign Capability in Drones, AI, and Counter-UAS Systems

Published

on

By

Canada becomes the first non-EU country to join the EU’s Security Action For Europe ‘SAFE’ initiativeEstimated to create 100 new high value tech jobs Target of 10,000 systems per month by 2029

TORONTO, June 30, 2026 /PRNewswire/ — Remote Robotic Systems (RRS) Inc. and Orqa d.o.o. are delighted to announce the signing of an exclusive partnership agreement to expand production of Orqa systems and components in Canada, with the goal of supplying both domestic and export markets. The agreement was signed by Orqa co-founder and CCO Ivan Jelusic and RSS CEO Kevin Toderel, with Mark Carney, Prime Minister of Canada, and Andrej Plenković, Croatian Prime Minister present, highlighting the significance of this deal. 

Canada is breaking new ground as the first non-European country to participate in the Security Action For Europe (SAFE) initiative, designed to increase the EU’s sovereign defense capabilities and reflecting the shared ambition of both parties to deepen their defence ties and strengthen joint security cooperation. 

The agreement is a significant milestone for the Croatian drone developer, marking the first deployment of its new Defense Transformation Platform, designed to help countries build sovereign drone ecosystems.  It will deliver strong growth and value for Canada, starting with an initial investment of $20M CAD to fund the expansion of RRS production facilities.

The deal itself is worth an estimated $150M CAD over the next five years, and will create up to 100 new high value technology jobs in Ottawa and Toronto by Q4 2027. The partners confidently expect to scale to 1000 systems per month by mid 2027, with a target of 10,000 per month over the course of the agreement.

Ivan Jelusic, CCO at Orqa, said, “This MoU will formalize the strategic framework for cooperation between RRS and Orqa to co-develop, manufacture, and commercialize advanced defence technologies. The specific focus is on uncrewed systems, counter-drone capabilities, and AI integration. RRS is the leading supplier of these systems to the armed forces and first responders in Canada, making them our ideal partner. We are committed to helping our allies create sovereign defence capabilities and this partnership is another step forward towards that goal.”

Kevin Toderel, CEO of RRS, added, “Orqa is the global leader in sUAS systems. We are proud to be able to build these systems in Canada and work with Orqa to increase capabilities and act as a supply chain and software development partner, bringing Canadian IP to the world. Our aim is to build Canadian capability and capacity for sUAS systems, ensuring Canada has ready access to this essential strategic resource now and in the future.”

The collaboration agreement defines four core areas:

Technology Transfer & Production Licensing: Orqa will facilitate the transfer of relevant technology and grant production licenses to RRS to enable localized Canadian manufacturing.Force & Capability Development: Joint development of solutions tailored to meet the evolving operational requirements of Canada’s armed forces, first responders and allied NATO partners.AI Implementation: Collaboration on the research, development, and integration of RRS’s sovereign AI capabilities onto mutually developed and manufactured platforms.Hub Establishment: Developing RRS’s facilities as Orqa’s second North American manufacturing hub and primary export launchpad into the continent’s broader defence and commercial market.

About Orqa. Orqa is Europe’s leading drone technology company, designing and manufacturing components and complete FPV/unmanned aerial systems in Croatia for customers in 50+ markets worldwide. Fully vertically integrated manufacturing ensures complete supply chain independence, with all key components made in the EU. Orqa is one of the fastest growing companies in Europe, ranked #135 overall – and #2 in Aerospace & Defense – in The Financial Times’ FT1000 list of Europe’s 1000 fastest-growing companies.

About Remote Robotic Systems.

Remote Robotic Systems is Canada’s largest and fastest growing drone provider, supplying the Canadian armed forces, 24 of the 25 largest public safety agencies, and some of Canada’s largest industrial drone fleets. With manufacturing in Ottawa and Mississauga, RRS is the leading supplier of domestically produced platforms to the Canadian forces and a pioneer in developing critical sovereign capabilities like the “Wingman” Co-Pilot and the Arctic Falcon platform. Our world-leading training programs ensure that operators are able to successfully complete complex missions in real-world environments.

#Orqa
#RemoteRoboticSystems

Photo – https://mma.prnewswire.com/media/3002016/RSS_Orqa_Partnership.jpg

View original content:https://www.prnewswire.co.uk/news-releases/orqa-and-remote-robotic-systems-launch-150m-partnership-to-build-canadian-sovereign-capability-in-drones-ai-and-counter-uas-systems-302813662.html

Continue Reading

Technology

Parabellum Investments Acquires Crux Informatics to Transform AI-Powered Data Infrastructure for Financial Markets

Published

on

By

LONDON and SAN FRANCISCO, June 30, 2026 /PRNewswire/ — Parabellum Investments (“Parabellum”), a leading investment firm specializing in enterprise software and fintech, today announced its acquisition of Crux Informatics, Inc. (“Crux”), the industry-leading platform for AI-powered external data management. 

In today’s global economy, data is the lifeblood of financial decision-making, yet the sheer volume and complexity of that data often create significant bottlenecks for institutions. Crux is solving this challenge by acting as the critical connective tissue between raw, fragmented data sources and the advanced models that power the world’s leading financial and technology firms.

The acquisition marks a major milestone for both organizations. Combining Crux’s platforms with Parabellum’s operational expertise and long-term growth strategy, the partnership will accelerate product innovation, broaden international reach, and deliver even greater efficiency to Crux’s customer base. 

Harnessing AI to Power Decision-Making

Crux streamlines the entire data lifecycle. Through its core offerings, Sphere (a full-cycle managed service for seamless data onboarding, transformations, and operations) and ArrayX (an agentic platform for rapid ingestion and self-healing pipelines), Crux changes how institutions interact with data. By automating complex processes like schema mapping, Crux enables data teams to shift focus from managing infrastructure to generating high-value insights.

With over 200 data providers, including Morningstar, Moody’s Analytics, and MSCI, and deep integrations with cloud destinations such as Google Cloud, Databricks, and Snowflake, Crux manages thousands of production customer data pipelines. The partnership with Parabellum will further accelerate Crux’s investment into frontier artificial intelligence, across a broad range of data-management and analytics workflows, including alpha-generating trading use cases. 

Rami Cassis, Principal of Parabellum, commented: “Crux plays an essential role in how leading organizations navigate the modern data landscape. They have built the definitive infrastructure for external data, and we are committed to investing in their continued evolution. This acquisition is a strategic addition to our portfolio and will enable us to deliver comprehensive, high-impact solutions to the financial sector.”

Will Freiberg, CEO of Crux, added: “Joining forces with Parabellum marks a pivotal moment for Crux. Their operational expertise and long-term vision align with our mission: to provide the fastest, most reliable path from raw data to actionable intelligence and alpha capture. With Parabellum’s support, we are doubling down on the AI-native features, like automated self-healing pipelines, that our customers rely on to maintain their competitive edge in fast-moving markets.”

D.A. Davidson acted as sole financial advisor to Crux in the transaction. Goodwin Procter LLP acted as legal advisor to Crux in the transaction. 

Terms of the transaction were not disclosed. For more information, please visit cruxdata.com and parabelluminvestments.com.

About Crux

Crux Informatics, Inc., provides data-management products to customers across the financial services and technology sectors. By cleaning, standardizing, and managing financial data from multiple external sources, the firm helps customers, including Goldman Sachs, Two Sigma, and Google Cloud, navigate market movements with greater ease and accuracy.

About Parabellum 

Parabellum Investments, led by Rami Cassis, is a private equity firm that acquires and scales high-potential companies across enterprise software, fintech, and life sciences. The firm deploys its own capital to acquire majority control of companies worldwide and accelerate their growth through operational excellence.

Parabellum Media Contact

Jordan Greenaway
parabellum@welcometoprofile.com

Logo – https://mma.prnewswire.com/media/3001970/Parabellum_Investments_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/parabellum-investments-acquires-crux-informatics-to-transform-ai-powered-data-infrastructure-for-financial-markets-302813606.html

Continue Reading

Trending